Market Overview

Benzinga's Top Upgrades, Downgrades For May 3, 2017

Share:

Top Upgrades

  • Analysts at Deutsche Bank upgraded Mondelez International Inc (NASDAQ: MDLZ) from Hold to Buy. Mondelez shares rose 3.27 percent to $45.20 in pre-market trading.
  • Analysts at Citigroup upgraded Frontier Communications Corp (NASDAQ: FTR) from Sell to Neutral. Frontier Communications shares dropped 11.34 percent to $1.72 in pre-market trading.
  • Analysts at Jefferies upgraded Helmerich & Payne, Inc. (NYSE: HP) from Underperform to Hold. Helmerich & Payne shares fell 0.12 percent to close at $58.72 on Tuesday.
  • JP Morgan upgraded Array Biopharma Inc (NASDAQ: ARRY) from Neutral to Overweight. Array BioPharma shares climbed 3.67 percent to $7.63 in pre-market trading.
  • William Blair upgraded FireEye Inc (NASDAQ: FEYE) from Market Perform to Outperform. FireEye shares surged 15.32 percent to $14.08 in pre-market trading.
  • Goldman Sachs upgraded McDonald's Corporation (NYSE: MCD) from Neutral to Buy. McDonald's shares rose 0.67 percent to $142.17 in pre-market trading.
  • Axiom Capital upgraded First Solar, Inc. (NASDAQ: FSLR) from Sell to Hold. First Solar shares gained 8.01 percent to $32.75 in pre-market trading.
  • Analysts at SunTrust Robinson Humphrey upgraded Oasis Petroleum Inc. (NYSE: OAS) from Neutral to Buy. Oasis Petroleum shares rose 2.23 percent to $11.90 in pre-market trading.
  • Mizuho upgraded Amedisys Inc (NASDAQ: AMED) from Neutral to Buy. Amedisys shares gained 1.63 percent to close at $56.09 on Tuesday.
  • Eight Capital upgraded Shopify Inc (US) (NYSE: SHOP) from Neutral to Buy. Shopify shares slipped 1.18 percent to $82.00 in pre-market trading.


Top Downgrades

  • Guggenheim downgraded Synchrony Financial (NYSE: SYF) from Buy to Neutral. Synchrony Financial shares dropped 3.5 percent to $27.86 in pre-market trading.
  • Compass Point downgraded Fidelity National Information Servcs Inc (NYSE: FIS) from Buy to Neutral. Fidelity National shares fell 1.37 percent to close at $83.26 on Tuesday.
  • Analysts at Macquarie downgraded Anadarko Petroleum Corporation (NYSE: APC) from Outperform to Neutral. Anadarko Petroleum shares fell 5.12 percent to $53.40 in pre-market trading.
  • Wells Fargo downgraded Charter Communications, Inc. (NASDAQ: CHTR) from Outperform to Market Perform. Charter Communications shares fell 1.87 percent to close at $337.69 on Tuesday.
  • Pacific Crest downgraded Twilio Inc (NYSE: TWLO) from Overweight to Sector Weight. Twilio shares slipped 32.2 percent to $23.34 in pre-market trading.
  • Raymond James downgraded Genomic Health, Inc. (NASDAQ: GHDX) from Outperform to Market Perform. Genomic Health shares dropped 2.4 percent to close at $32.91 on Tuesday.
  • Analysts at SunTrust Robinson Humphrey downgraded Akamai Technologies, Inc. (NASDAQ: AKAM) from Buy to Hold. Akamai shares dropped 14.2 percent to $53.64 in pre-market trading.
  • BMO Capital downgraded Bristol-Myers Squibb Co (NYSE: BMY) from Market Perform to Underperform. Bristol-Myers shares fell 0.84 percent to $55.48 in pre-market trading.
  • JP Morgan downgraded Verisk Analytics, Inc. (NASDAQ: VRSK) from Overweight to Neutral. Verisk Analytics shares dropped 8.65 percent to $75.00 in pre-market trading.
  • William Blair downgraded Potbelly Corp (NASDAQ: PBPB) from Outperform to Market Perform. Potbelly shares fell 14.1 percent to $11.90 in pre-market trading.


Top Initiations

  • Analysts at Susquehanna initiated coverage of Carvana Co (NYSE: CVNA) with a Neutral rating. The price target for Carvana is set to $10. Carvana shares closed at $10.10 on Tuesday.
  • Analysts at Baird initiated coverage on LCI Industries (NYSE: LCII) with an Outperform rating. The price target for LCI Industries is set to $118. LCI Industries shares closed at $101.25 on Tuesday.
  • Analysts at Cowen & Co. initiated coverage on Viveve Medical Inc (NASDAQ: VIVE) with an Outperform rating. The price target for Viveve Medical is set to $11. Viveve Medical shares closed at $8.09 on Tuesday.
  • Analysts at Mizuho initiated coverage on Hi-Crush Partners LP (NYSE: HCLP) with a Buy rating. The price target for Hi-Crush Partners is set to $20. Hi-Crush Partners shares closed at $14.70 on Tuesday.
  • Analysts at Deutsche Bank initiated coverage on C&J Energy Services, Inc. (NYSE: CJ) with a Buy rating. The price target for C&J Energy is set to $43. C&J Energy shares closed at $29.96 on Tuesday.
  • Analysts at William Blair initiated coverage of Bob Evans Farms Inc (NASDAQ: BOBE) with an Outperform rating. Bob Evans Farms shares closed at $68.00 on Tuesday.
  • Analysts at Wells Fargo initiated coverage on Apple Hospitality REIT Inc (NYSE: APLE) with a Market Perform rating. Apple Hospitality REIT shares closed at $19.00 on Tuesday.
  • Ladenburg Thalmann initiated coverage on EnteroMedics Inc (NASDAQ: ETRM) with a Buy rating. The price target for EnteroMedics is set to $11. EnteroMedics shares closed at $4.17 on Tuesday.

Latest Ratings for MDLZ

DateFirmActionFromTo
Oct 2019Initiates Coverage OnOutperform
Aug 2019UpgradesEqual-WeightOverweight
Jul 2019MaintainsOutperform

View More Analyst Ratings for MDLZ
View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (AKAM + AMED)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TOLGoldman SachsInitiates Coverage On42.0
KBHGoldman SachsInitiates Coverage On36.0
YEXTSunTrust Robinson HumphreyMaintains28.0
LHCGSunTrust Robinson HumphreyMaintains160.0
DLRSunTrust Robinson HumphreyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Gene Munster Talks Apple Growth: 'It's Still All About The iPhone 10'

Apple's Q2 Results And The Importance Of Augmented Reality